PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2147/DDDT.S261154
?:doi
?:hasPublicationType
?:journal
  • Drug design, development and therapy
is ?:pmid of
?:pmid
?:pmid
  • 32821086
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 40
is ?:relation_isRelatedTo_publication of
?:title
  • A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all